Therefore, coronary sinus (CS) narrowing, using the Reducer device, was suggested. During the procedure, angiography revealed an aneurysmatic CS (Figure 1A). As the Reducer is available in one size [Citation1], a similar to the device's maximal diameter (9.00mm) peripheral balloon was used ...
The device used in Banai et al's study is the Coronary Sinus Reducer (Neovasc Medical, Or Yehuda, Israel), and it was developed on the basis of observations that increased pressure in the coronary sinus can help enhance perfusion of ischemic portions of the heart. The stent itself, introduce...
The title of the article is: "Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients." The main findings of the study are that: the Reducer decreases healthcare burden of refractory angina patients and the associated costs across a...
The coronary sinus reducer (CSR), a minimally invasive device, has emerged as a promising alternative for improving myocardial perfusion in these patients. This meta-analysis evaluated the effectiveness of CSR implantation in patients with refractory angina. A ...
The Coronary Sinus Reducer (CSR) is a novel device that improves symptoms and quality of life in patients with refractory angina secondary to advanced coronary artery disease (CAD) 1, 2, 3. The COSIRA trial, the first randomised, double-blinded, sham-controlled trial of CSR implantation, demo...
Coronary sinus reducer (CSR) implantation is a safe and effective therapy for patients with refractory angina. We aimed to evaluate the clinical efficacy of reducer implantation in relieving angina in patients with CTO. Methods Patients with refractory angina and no-option for revascularization who ...
Banai S et al (2007) Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris, a prospective, open label, multicenter, safety feasibility first-in-man study. J Am Coll Cardiol 49:1783–1789 Article PubMed Google Scholar Harnek J et al (2011) Transcatheter implantat...
Shinfeld to our article entitled 'Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience' [1]. We agree with them that the Beck-II [2] procedure has little in common with the coronary sinus reducer as ...
Reply to comments from Paz and Shinfeld to article entitled 'Safety and efficacy of adevice to narrow the coronary sinus for the treatment of refractory an... The coronary sinus Reducer is a recently introduced device to treat patients with severe angina symptoms refractory to optimal medical ...
Two contemporary RCTs have demonstrated the feasibility of placebo-controlled trials in patients with stable CAD: the COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) (97) and the ORBITA trials (14). In the COSIRA trial, 104 participants with refractory angina were randomized ...